• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Crescendo Bioscience

edit

Crescendo Bioscience, Inc. develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory diseases. It provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians. Crescendo Bioscience, Inc. was formerly known as Riley Genomics, Inc. The company was founded in 2002 and is based in South San Francisco, California.

Recent Milestones

edit

• 
  Crescendo Bioscience received $28M in Series D funding. (1/3/13)
  Posted 1/3/13 at 8:40pm via dowjones.com
• 
  Crescendo Bioscience received $56M in Series C funding. (9/8/11)
  Posted 9/8/11 at 10:40pm via crescendobio.com
• 
  Crescendo Bioscience received $5M in Series B funding. (10/30/09)
  Posted 11/30/09 at 6:06pm via venturebeat.com
• 
  Crescendo Bioscience added David Gilboa as Business Development and Strategy Intern. (6/1/09)
  Posted 4/30/13 at 3:15am
• 
  Crescendo Bioscience added Ted Snelgrove as Chief Commercial Officer. (1/1/08)
  Posted 3/10/10 at 3:39pm
• 
  Crescendo Bioscience added Lisa C. Ocheltree as CFO.
  Posted 11/30/09 at 6:06pm
• 
  Crescendo Bioscience added William Hagstrom as CEO.
  Posted 11/30/09 at 6:06pm
• 
  Crescendo Bioscience added Michael B. Centola as Co-Founder and Chief Scientific Officer .
  Posted 11/30/09 at 6:06pm

Videos

Screenshots

edit

Above: Home Page
Uploaded: 12/1/09

Sources

1. Crescendo tacks on $5M more for autoimmune disease testing (deals.venturebeat.com) [edit]
2. Crescendo Bioscience® Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics for Inflammatory Diseases (crescendobio.com) [edit]
3. Crescendo Bioscience Raises $28M to Sell Arthritis-Tracking Blood Tests (pevc.dowjones.com) [edit]